...
首页> 外文期刊>Liver international : >Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure
【24h】

Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure

机译:慢性肝衰竭预测急性肾损伤急性肾损伤,损伤,反应,器官衰竭模型的发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background and Aim There is limited data on predictors of acute kidney injury in acute on chronic liver failure. We developed a PIRO model (Predisposition, Injury, Response, Organ failure) for predicting acute kidney injury in a multicentric cohort of acute on chronic liver failure patients. Patients and Methods Data of 2360 patients from APASL ‐ ACLF Research Consortium ( AARC ) was analysed. Multivariate logistic regression model ( PIRO score) was developed from a derivation cohort (n=1363) which was validated in another prospective multicentric cohort of acute on chronic liver failure patients (n=997). Results Factors significant for P component were serum creatinine[(≥2?mg/dL) OR 4.52, 95% CI (3.67‐5.30)], bilirubin [(12?mg/ dL , OR 1) vs (12‐30?mg/ dL , OR 1.45, 95% 1.1‐2.63) vs (≥30?mg/ dL , OR 2.6, 95% CI 1.3‐5.2)], serum potassium [(3?mmol/ LOR ‐1) vs (3‐4.9?mmol/L, OR 2.7, 95% CI 1.05‐1.97) vs (≥5?mmol/L, OR 4.34, 95% CI 1.67‐11.3)] and blood urea ( OR 3.73, 95% CI 2.5‐5.5); for I component nephrotoxic medications ( OR ‐9.86, 95% CI 3.2‐30.8); for R component,Systemic Inflammatory Response Syndrome,( OR ‐2.14, 95% CI 1.4‐3.3); for O component, Circulatory failure ( OR ‐3.5, 95% CI 2.2‐5.5). The PIRO score predicted acute kidney injury with C‐index of 0.95 and 0.96 in the derivation and validation cohort. The increasing PIRO score was also associated with mortality ( P .001) in both the derivation and validation cohorts. Conclusions The PIRO model identifies and stratifies acute on chronic liver failure patients at risk of developing acute kidney injury. It reliably predicts mortality in these patients, underscoring the prognostic significance of acute kidney injury in patients with acute on chronic liver failure.
机译:摘要背景和宗旨有限数据急性肾损伤预测因子急性肾脏损伤。我们开发了一种Piro模型(易感性,损伤,反应,器官衰竭,用于预测慢性肝功能衰竭患者的多中心竞争中的急性肾损伤。分析了APASL - ACLF研究联盟(AARC)2360例患者的患者和方法。从衍生队队(n = 1363)开发了多变量逻辑回归模型(Piro评分),其在慢性肝功能衰竭患者的另一种前瞻性多中心队列中验证(n = 997)。 P组分的显着性因子是血清肌酐[(≥2×mg / dl)或4.52,95%Ci(3.67-5.30)],胆红素[(& 12?mg / dl,或1)Vs(12-30 ?Mg / dl,或1.45,95%1.1-2.63)Vs(≥30?mg / dl,或2.6,95%Ci 1.3-5.2),血清钾[(& 3?mmol / lor -1)vs (3-4.9?mmol / l,或2.7,95%ci 1.05-1.97)与血液尿素(或3.73,95%ci 2.5 -5.5);对于I组分肾毒药药物(或-9.86,95%CI 3.2-30.8);对于R组分,全身炎症反应综合征,(或-2.14,95%CI 1.4-3.3);对于O组分,循环衰竭(或-3.5,95%CI 2.2-5.5)。 Piro评分在推导和验证队列中预测急性肾脏损伤0.95和0.96的C折射率。增加的Piro评分在推导和验证队列中的死亡率(P& .001)也有关。结论Piro模型鉴定和分层急性肾损伤风险急性肝衰竭患者。它可靠地预测这些患者的死亡率,强调急性肾损伤对慢性肝衰竭急性肾损伤的预后意义。

著录项

  • 来源
    《Liver international :》 |2017年第10期|共11页
  • 作者单位

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of Clinical HematologyCommand Hospital [Eastern Command]Kolkata India;

    Department of Clinical ResearchInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of Clinical ResearchInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of Clinical ResearchInstitute of Liver and Biliary SciencesNew Delhi India;

    UMR_S1149Inserm and Paris Diderot UniversityParis France;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of GastroenterologyZiauddin University HospitalKarachi Pakistan;

    Department of Gastroenterology and HepatologyBombay Hospital and Medical ResearchMumbai India;

    Department of Clinical ResearchInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of PathologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of MedicineAga Khan University HospitalKarachi Pakistan;

    Department of SurgeryThe University of Hong KongHong Kong China;

    Department of HepatologyPost Graduate Institute of Medical Education and ResearchChandigarh India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyPost Graduate Institute of Medical Education and ResearchChandigarh India;

    Department of GastroenterologyAnkara University School of MedicineAnkara Turkey;

    Department of HepatologyNork Clinical Hospital of Infectious DiseasesYerevan Armenia;

    Department of MedicineAga Khan University HospitalKarachi Pakistan;

    Center for Liver and Digestive DiseasesHallym University Chuncheon Sacred Heart HospitalGangwon‐Do;

    Department of MedicineChulalongkorn UniversityBangkok Thailand;

    Department of HepatologyThe Institute of Translational HepatologyBeijing China;

    Department of MedicineNational University Health SystemSingapore Singapore;

    Division of HepatologyUniversity of IndonesiaJakarta Indonesia;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyBangabandhu Sheikh Mujib Medical UniversityDhaka Bangladesh;

    Department of NephrologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of NephrologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of Infectious DiseaseHuazhong University of Science and TechnologyWuhan China;

    Department of Hepatobiliary SurgeryInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyCardinal Santos Medical CenterManila Philippines;

    Department of PathologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyBangabandhu Sheikh Mujib Medical UniversityDhaka Bangladesh;

    Institute of Liver diseases and TransplantationGlobal Health cityChennai India;

    Department of GastroenterologySanjay Gandhi Post Graduate Institute of Medical SciencesLucknow India;

    Department of HepatologyGlobal HospitalsMumbai India;

    Department of Internal MedicineEgyptian Liver Research Institute and HospitalCairo Egypt;

    Department of GastroenterologyGB Pant HospitalNew Delhi India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of Hepatology Selayang HospitalSelangor Malaysia;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of HepatologyInstitute of Liver and Biliary SciencesNew Delhi India;

    Department of MedicineThe University of Hong KongHong Kong China;

    Department of Gastroenterology and NephrologyChiba UniversityChiba Japan;

    Department of HepatologyPost Graduate Institute of Medical Education and ResearchChandigarh India;

    Department of MedicineAga Khan University HospitalKarachi Pakistan;

    Department of GastroenterologySt.John’s Medical College and HospitalBangalore India;

    Department of Gastroenterology and HepatologyCMCVellore India;

    Department of GastroenterologyRome NY USA;

    Department of GastroenterologyDayanand Medical College and HospitalLudhiana India;

    Department of GastroenterologyLiver Research CenterBeijing China;

    Department of GastroenterologyNanjing First HospitalNanjing China;

    Department of GastroenterologyEast Brunswick NJ USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    acute kidney injury; acute on chronic liver failure; liver failure; Multiple organ failure; PIRO;

    机译:急性肾损伤;慢性肝衰竭急性;肝功能衰竭;多器官失败;Piro;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号